ETF Website
.jpg?sfvrsn=b08fa076_2){kind=spacer}
.jpg?)
View Performance of the funds managed by the Fund Manager
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies/Entities benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns. s
There is no assurance that the investment objective of the Scheme will be achieved.
The scheme has atleast 80% investments in Pharma, Healthcare and allied sectors.
Healthcare is an evolving theme which has tremendous growth potential and includes businesses in hospitals, diagnostics, specialty chemicals, medical equipment, insurance and other allied sub sectors.
The endeavor is to maintain a concentrated portfolio of 30-40 stocks in this theme.
Fund has the flexibility to invest across market capitalization and style in selecting investment opportunities within this theme.
Sectoral - An open ended equity scheme investing in healthcare and allied sectors
Mr. Vrijesh Kasera - since (02nd July, 2018)
Mr. Tanmay Mehta - since (1st April 2025)
2nd July, 2018
BSE Healthcare Index (TRI)
Rs. 99 & in multiples of Re. 1 thereafter
Rs.500 & in multiples of Re. 1 thereafter
Regular Plan and Direct Plan
Growth Option and IDCW (Payout / Reinvestment)
Recommended Investment Horizon
5+Years
Investments in Healthcare and allied sectors.
Wealth Creation
For Historic NAV Click here
| Record date | Div. Ind (₹) | Div. Corp (₹) | Cum Nav (₹) |
For Historic Dividend Click here
Mirae Asset Equity Investment Process and Philosophy
Since 2nd July 2018
Since 1st April 2025
Mirae Asset Healthcare Fund is suitable for investors who are seeking long-term capital appreciation through investments in equity and equity-related securities of companies and entities that benefit directly or indirectly from the healthcare and allied sectors in India. The fund aims to provide investors with an opportunity to participate in the potential growth of India's healthcare industry. The scheme's riskometer indicates that the risk associated with the scheme is Very High. Similarly, the benchmark riskometer, based on the AMFI Tier 1 Benchmark and the BSE Healthcare Index (TRI), also indicates a Very High risk level. Investors should carefully evaluate their risk appetite and investment objectives before investing. If investors are unsure about the suitability of this product, they should consult their financial advisor.
This Product label is suitable for investors who are seeking:
To generate Long-term capital appreciation
Investments in equity and equity related securities of companies/Entities benefitting directly or
indirectly in Healthcare and allied sector in India
View Performance of the funds managed by the Fund Manager
How to achieve your goal
28
45
92
| Name | Allocation |
73.13%
18.51%
3.94%
4.35%
*Data as on 31st March, 2022.
